<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Anthera Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals
    Invest Now

    About Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      Start Engine
    • RAISED AMOUNT
      $65,500,000
    • PRE-MONEY EVAULATION
      $8,811,000.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Paul F. Truex
    • FOUNDED
      2004
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    GenMark Diagnostics, Inc.

    GenMark Diagnostics, Inc.

    GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular di...

    GenMark Diagnostics (NASDAQ: GNMK) is a leading...

    Filing Type:    PU
    Accuray Incorporated

    Accuray Incorporated

    Accuray develops, manufactures and sells radiation oncology systems that make canc...

    Accuray develops, manufactures and sells radiat...

    Filing Type:    PU
    Immutep Limited

    Immutep Limited

    We are a biotechnology company developing novel immunotherapy treatments for cance...

    We are a biotechnology company developing novel...

    Filing Type:    PU
    Alzamend Neuro, Inc

    Alzamend Neuro, Inc

    Alzamend Neuro™, Inc. (“Alzamend™”) is a biotechnology company dedicated t...

    Alzamend Neuro™, Inc. (“Alzamend™”) is ...

    Filing Type:    RA
    Magellan Health, Inc.

    Magellan Health, Inc.

    Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest ...

    Magellan Health, Inc., a Fortune 500 company, i...

    Filing Type:    PU
    Selecta Biosciences, Inc.

    Selecta Biosciences, Inc.

    Selecta Biosciences, Inc. is a clinical-stage biotechnology company focused on unl...

    Selecta Biosciences, Inc. is a clinical-stage b...

    Filing Type:    PU
    Eyegate Pharmaceuticals, Inc.

    Eyegate Pharmaceuticals, Inc.

    EyeGate is developing and commercializing products for treating diseases and disor...

    EyeGate is developing and commercializing produ...

    Filing Type:    PU
    Merrimack Pharmaceuticals, Inc.

    Merrimack Pharmaceuticals, Inc.

    Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is...

    Merrimack is a biopharmaceutical company based ...

    Filing Type:    PU
    Scholar Rock Holding Corporation

    Scholar Rock Holding Corporation

    Scholar Rock is a biopharmaceutical company focused on the discovery and developme...

    Scholar Rock is a biopharmaceutical company foc...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.